hVIVO

H1 2026 results

  • Sep 15 2026, 07:10 IST/BST
  • Colin Grant
  • Company Report
  • 6 page(s)
  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 6.4p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

Person's Name

Colin Grant

Analyst

DAVY VIEW

hVIVO’s H1 2026 results had largely already been given in its July trading statement. The order book is rebounding as commercial activity improves and is supported by the post period-end acquisition of CRS Berlin. Guidance for FY2026 reflects some revenues we expected in 2026 now likely to occur in 2027/2028.

View full article

Download full report with analyst certification and important disclosures

Sep 15 2026, 07:10 IST/BST

Download